Report cover image

Global Burns and Scalds Treatment Market Growth 2025-2031

Published Aug 15, 2025
Length 184 Pages
SKU # LPI20314325

Description

The global Burns and Scalds Treatment market size is predicted to grow from US$ 472 million in 2025 to US$ 592 million in 2031; it is expected to grow at a CAGR of 3.9% from 2025 to 2031.

Burn and scald medicines refer to medicines used to treat skin or tissue damage caused by heat (such as flames, hot water, steam), chemicals, electric current or radiation. The main functions of these medicines are to relieve pain, prevent infection, promote wound healing and reduce scar formation. According to the severity and type of burns, burn and scald medicines can be divided into topical medicines, oral medicines and new therapies.

United States market for Burns and Scalds Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Burns and Scalds Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Burns and Scalds Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Burns and Scalds Treatment players cover MEBO, B. Braun, Integra LifeSciences, Tianjin Pharmaceutical Da Ren Tang Group Corporation, Smith & Nephew, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Burns and Scalds Treatment Industry Forecast” looks at past sales and reviews total world Burns and Scalds Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Burns and Scalds Treatment sales for 2025 through 2031. With Burns and Scalds Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Burns and Scalds Treatment industry.

This Insight Report provides a comprehensive analysis of the global Burns and Scalds Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Burns and Scalds Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Burns and Scalds Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Burns and Scalds Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Burns and Scalds Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Burns and Scalds Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Salve
Spray
Oil
Other

Segmentation by Application:
Hospitals and Clinics
Retail Pharmacies
E-commerce Platforms
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MEBO
B. Braun
Integra LifeSciences
Tianjin Pharmaceutical Da Ren Tang Group Corporation
Smith & Nephew
Yangtze River Pharmaceutical
STADA Thornton & Ross
Kenvue Brands LLC
Changchun OVERSEAS
Orkla Health
Guangdong Hengjian Investment
Otsuka Pharmaceutical Co
Tonghua Maoxiang Medical Co
Cipla
Mitsubishi Tanabe Pharma Corporation
Chongqing GankyilL Bio-Technology
Quest Products, LLC
Jianmin Pharmaceutical Group Co
Acme United Corp.
Dongwha Pharm
CR Pharmaceutical Commercial Group Co
Safetec Of America
Chongqing Taiji Industry
North China Pharmaceutical Co
Xiangxi Hongcheng
Aoxing Pharmaceutical
Jilin Aodong Pharmaceutical Group Co
Beijing Tong Ren Tang Chinese Medicine Co

Key Questions Addressed in this Report

What is the 10-year outlook for the global Burns and Scalds Treatment market?

What factors are driving Burns and Scalds Treatment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Burns and Scalds Treatment market opportunities vary by end market size?

How does Burns and Scalds Treatment break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

184 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Burns and Scalds Treatment by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Burns and Scalds Treatment by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.